Patent details

EP1690536 Title: Use of r-(+)-2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxy-methyl -phenylisobutyric acid ester hydrogenfumarate for the treatment of urinary incontinence and other spasmogenic disorders.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP1690536
WO Application Number:
Type:
European Patent Granted for NL
Status:
Expired. Art. 36.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP06011207.5
WO Publication Number:
EPO Publication Language:
German
SPC Number:
First Applicant Residence Country:
Germany (DE)
Publications:

Dates

Filing date:
15/11/2000
Grant date:
14/05/2008
EP Publication Date:
14/05/2008
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
14/05/2008
EP B1 Publication Date:
14/05/2008
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
14/11/2020
Lapsed By Expiration Date:
15/11/2020
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
28/09/2017
 
 

 

Name:
UCB Pharma GmbH
Address:
Alfred-Nobel-Strasse 10, D-40789, Monheim, Germany (DE)

Historical Applicant/holder

From:
14/05/2008
To:
28/09/2017

 

Name:
SCHWARZ PHARMA AG
Address:
Alfred-Nobel-Strasse 10, D-40789, Monheim, Germany (DE)

Domicile Holder

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
14/05/2008
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

Name:
Claus Meese
Address:
40789, Monheim, Germany (DE)

Licensee

Name:
Pfizer lnc.
From:
28/09/2017
Address:
235 East 42nd Street, 10017, New York, NY, United States of America (US)
To:

Priority

Priority Patent Number:
19955190
Priority Date:
16/11/1999
Priority Country:
Germany (DE)

Classification

Main IPC Class:
A61K 31/222;
IPC or IDT classification:
A61P 13/06;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
47/20
Publication date:
18/11/2020
Description:
Lapse or annulment

2

Bulletin Heading:
CO
Journal edition number:
45/17
Publication date:
08/11/2017
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
MED
Journal edition number:
45/17
Publication date:
08/11/2017
Description:
Other communications

4

Bulletin Heading:
EP3
Journal edition number:
2008/11
Publication date:
03/11/2008
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

5

Bulletin Heading:
EP2
Journal edition number:
2008/07
Publication date:
01/07/2008
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
200820
Publication date:
14/05/2008
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC201701930A
Date Registered:
28/09/2017
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
UCB Pharma GmbH
Address:
Alfred-Nobel-Strasse 10, D-40789, Monheim, Germany (DE)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Licence

Change Kind/ Decision Type:
New licence registration
Deed Number:
RC201701930B
Date Registered:
28/09/2017
License Effective Date:
28/09/2017
License Expiration Date:
Scope of License:
Exclusive
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Licensee(s)

Name:
Pfizer lnc.
Address:
235 East 42nd Street, 10017, New York, NY, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
14/11/2019
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
1400 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
06/11/2017 Outgoing Correspondence Letter registration deed 1 PDF /7/0/2/1/1/0506011207/docs/ep06011207.5_0_172705l118.pdf
28/09/2017 Request for Change First filed deed 13 PDF /7/0/2/1/1/0506011207/docs/ep06011207.5_2_rfc20171024120211373.pdf
07/08/2008 Drawings First filed drawings 1 PDF /7/0/2/1/1/0506011207/docs/ep06011207.5_1_drawings20080807.pdf
07/08/2008 Claims Translated claims 1 PDF /7/0/2/1/1/0506011207/docs/ep06011207.5_3_claims20080807.pdf
07/08/2008 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /7/0/2/1/1/0506011207/docs/ep06011207.5_4_incomingcorrespondencepaper20080807.pdf
07/08/2008 Outgoing Correspondence Outgoing Letter 1 PDF /7/0/2/1/1/0506011207/docs/ep06011207.5_5_outgoingcorrespondence20080807.pdf
07/08/2008 Description Translated description 9 PDF /7/0/2/1/1/0506011207/docs/ep06011207.5_7_description20080807.pdf
16/05/2008 Incoming Correspondence Paper Correspondence address details 1 PDF /7/0/2/1/1/0506011207/docs/ep06011207.5_6_incomingcorrespondencepaper20080516.pdf